Cancer Blog

Here's our collection of cancer-related stories. We sift through a variety of stories and share the issues that we think matter to cancer patients, caregivers, healthcare providers and survivors. Learn about current events in the cancer community, human interest stories, and promising technology and treatment advances. Tell us what you think in the Comments section at the bottom of each post.

Note: The information contained in this service is not intended nor implied to be a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition. Nothing contained in the service is intended to be used for medical diagnosis or treatment of any illness, condition or disease.

Sep

10

Permalink Comment RSS (0)

Lance Armstrong Ends Retirement to Raise Cancer Awareness

by: cancercompass

Seven-time winner of the Tour de France, cyclist Lance Armstrong has announced he is coming out of retirement.

In addition to his goal of winning an eighth Tour de France, Armstrong says his return to professional cycling is intended to raise cancer awareness on a global scale.

In a statement released to the press Armstrong stated, "I am happy to announce that after talking with my children, my family and my closest friends, I have decided to return to professional cycling in order to raise awareness of the global cancer burden. This year alone, nearly eight million people will die of cancer worldwide."

In 1996 Armstrong was diagnosed with testicular cancer, which spread to his abdomen, lungs and brain. Through surgery and chemotherapy he was able to beat the disease.

Armstrong has since waged war upon cancer. The 36-year-old Texan created LIVESTRONG, a foundation to raise knowledge of the disease and funds for research programs. He has also appeared on Capitol Hill to call on Congress to battle cancer.

Armstrong is scheduled to appear in New York City later this month to share details of his cycling program and an international LIVESTRONG strategy.

 

Sep

09

Permalink Comment RSS (0)

HPV Test Detects Cervical Cancer

by: cancercompass

Using a common test for the human papillomavirus (HPV), researchers say they have discovered a more accurate way to test women for cervical cancer.

According to a recent Reuters article, Italian researchers have combined the HPV test with another test that identifies pre-cancerous cell damage. The second test is used to identify a protein called P16INK4A. This protein acts as a biomarker, which signals pre-cancerous cell changes in the cervix.

The researchers say this testing process is more accurate than a pap smear, identifying 50% more pre-cancerous cell damage.

The results from the study have been published in the journal Lancet Oncology.

To learn more about cervical cancer detection, visit our Cervical Cancer Information page.

 

Sep

08

Permalink Comment RSS (0)

Stand Up to Cancer Telethon Raises $100M

by: cancercompass

The star-studded Stand Up to Cancer Telethon has reportedly raised more than $100 million to help fund cancer research programs.

The hour-long telethon aired last Friday night on ABC, CBS and NBC, and pulled in 10.3 million viewers.

Celebrity cancer survivors such as Lance Armstrong, Sheryl Crowe, Christina Applegate, and Patrick Swayze, in addition to stars from music, sports, TV and film, helped educate the public on cancer prevention and treatment. ABC, CBS and NBC news anchors Charles Gibson, Katie Couric and Brian Williams hosted the event.

According to Lisa Paulsen, head of the charity organization responsible for the event, 100% of the money raised from the telethon will directly fund cancer research programs.

Stand Up to Cancer is continuing to raise funds for cancer research programs. For information, visit the Stand Up to Cancer website.

 

Sep

05

Permalink Comment RSS (0)

New Breast Cancer Screening Technique

by: cancercompass

A screening technique called molecular breast imaging (MBI) is making headlines as a powerful breast cancer detection tool.

According to a recent research study, MBI performed 3 times better than mammography in detecting breast cancer tumors in women with dense breast tissue.

Mammogram X-rays frequently have trouble detecting small tumors in women with dense breast tissue. About 25% of women 40 and older have dense breast tissue.

Using the MBI technique, patients receive a radioactive agent injection that is absorbed by cancer cells in the breast tissue. Using specialized cameras, doctors are able to identify the tumors.

Researchers expect MBI to be used as an additional tool for detecting cancer in women with dense breast tissue.

The MBI research is one of a number of studies being presented this week at the American Society of Clinical Oncology's 2008 Breast Cancer Symposium in Washington, D.C.

 

Sep

05

Permalink Comment RSS (0)

Prostate Cancer Risk May Increase with Height

by: cancercompass

A recent study shows that taller men may have an increased risk of being diagnosed with prostate cancer.

According to a New York Times article, the study was a collaboration between researchers at four universities in England.

The researchers studied more than 9,000 men and discovered a 19% higher risk of prostate cancer among the tallest men studied, compared to the shorter men.

The study acknowledges that height is less of a risk factor than age, family history, and race, but the findings may influence future research on the causes of prostate cancer.

The research has been published in a recent issue of Cancer Epidemiology Biomarkers & Prevention.

 

Sep

02

Permalink Comment RSS (0)

Drug Blocks Endometrial Cancer Growth

by: cancercompass

Researchers at the Translational Genomics Research Institute (TGen) in Phoenix, Arizona say they have discovered a new treatment for fighting endometrial cancer.

Endometrial cancer forms in the tissue lining of the uterus. According to the National Cancer Institute, endometrial cancer will cause nearly 7,500 deaths in the U.S. this year.

TGen researchers say an experimental drug called PD173074 stops the growth of endometrial tumors and kills the cancer cells.

The drug also proved effective against cancer tumors containing PTEN, a mutant gene known for its resistance to drug treatments.

The TGen findings have been published in Cancer Research as a Priority Report.

Clinical trials are scheduled to take place in St. Louis, Missouri.

 

We care about your feedback. Let us know how we can improve your CancerCompass experience.